Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Charles River Laboratories International, a provider of preclinical, clinical, and support services, has opened its 60,000 square foot preclinical facility in Shanghai, China to support the growing demand from multinational pharmaceutical clients for outsourced drug development services.
Subscribe to our email newsletter
The new China facility is said to position Charles River as the strategic partner of choice to fully support clients’ global drug development needs.
James Foster, president, chairman and CEO of Charles River, said: “Our clients have come to appreciate and rely on the expertise Charles River brings to their drug development efforts, and the convenience of our facilities in close proximity.
“The same high standards of research, safety, humane care and good laboratory practices that globally distinguish Charles River are replicated in our Shanghai facility. Expanding into this arena is a marathon – not a sprint – and this facility marks the first step in our journey.”